What are the submission requirements for this tender (Ref: HP07-2026DAI/01)?

Submission format and sequence: - All bid documents must be sorted, filed, and submitted in the exact order listed in the returnable documents schedule (Annexure A). - Each compilation sequence (document) must be saved as a separate file on the USB flash drive, using the admin code abbreviations in the file name. - A digital copy of the completed bid must be provided on a USB flash drive (Set 2 & 3). - The Excel Bid Response (Pricing Schedule) must be signed in the space provided; unsigned pricing schedules will result in the bid not being considered for evaluation. - If a specific document is not applicable, the bidder must explicitly indicate "N/A" and provide a justification for its exclusion. Sections blacked out in the "N/A" field are not valid selection options. Mandatory returnable forms and documents: - Covering Letter (CL) – Administrative - Bid/File Index (BFI) – Administrative - PBD 3: Bid Signature Authorisation (original or certified copy) – Mandatory - SBD 1: Invitation to Bid – Mandatory for bidding entity - PBD 4.1: Contact Details of Bidder – Administrative - CSD Registration report – Mandatory - SARS Tax Clearance Pin – Mandatory - CIPC registration certificate – Mandatory - CIPC notice of change in Directors – Administrative - Proof of company ceding, mergers, acquisition, and name changes – Administrative - PBD 9.1: Entity Directors – Administrative (if single bidding entity) - PBD 9.2: Multi-entity Bid – Administrative (if multi bidding entity) - Identification documents of Directors in PBD 9.1 or PBD 9.2 – Administrative (certified copies required) - SBD 4: Declaration of Interest – Mandatory for bidding entity - SBD 6.1: Preference Points Claim – Mandatory - Valid B-BBEE Certificate (SANAS accredited) – Mandatory where applicable - Sworn Affidavit – Exempted Micro Enterprise (EME) – Mandatory where applicable - Sworn Affidavit – Qualified Small Enterprise (QSE) – Mandatory where applicable - Multi-entity Bids: Certified copy of relevant agreement between entities including all other mandatory documents as specified in Section 7.13 – Mandatory - PBD 11: Declaration of Financial Solvency and Business Rescue Status – Mandatory - PBD 5: Good Manufacturing Practice (GMP) Declaration of compliance – Mandatory (authorised signatory per PBD 3 to sign) - SBD 5: National Industrial Participation Programme – Mandatory for bidding entity - Valid licence to manufacture or import (in the name of the bidder), including all annexures – Mandatory (certified copies required) - Valid licence to manufacture or import for local manufacturing sites as listed on the MRC – Mandatory (preference for locally produced products; certified copies required) - Valid licence to manufacture/import/distribute/wholesale Complementary Medicines – Mandatory (certified copies required) - All annexures and DA02 product list for Complementary Medicines – Administrative (certified copies required) - Valid licence to manufacture/import/distribute/wholesale a medical device or IVD – Mandatory (certified copies required) - Valid Medicine Registration Certificates (MRC) – Mandatory (all MRCs to be marked with relevant item number, sorted and filed in numerical order; certified copies required) - MRC Annexures as issued by SAHPRA – Administrative (certified copy required) - Valid Variation Summary for any changes on the MRC per SAHPRA Guideline: BAU VARIATIONS COMMUNICATION latest version – Administrative (certified copies required) - PBD 1: Third Party Authorisation Declaration – Administrative - PBD 1.1: List of products offered sourced from third party – Administrative - PBD 1.2: Unconditional written undertaking from the third party or formal letter – Administrative - Original Package Insert (PI), QR code with professional information approved by MCC or SAHPRA – Administrative (for each product offered) - Proof of sample submission – Administrative - Bidder's item list (list of products offered) – Administrative - PBD 8: SRCC and GCC Declaration of compliance – Mandatory for bidding entity (authorised signatory per PBD 3 to sign) - Copy of Special Requirements and Conditions of Contract (SRCC) – initial every page – Mandatory - Copy of General Conditions of Contract (GCC) – initial every page – Mandatory - Signed Excel Bid Response (Pricing Schedule) – Mandatory

What are the technical specifications?

Scope: Supply and delivery of pharmaceutical products — drops, aerosols and inhaled medicines — to the Department of Health for the period ending 31 August 2029. Regulatory and technical requirements: - Bidders must hold a valid licence to manufacture or import (in the name of the bidder) including all annexures; certified copies required. - For local manufacturing sites listed on the Medicine Registration Certificate (MRC), a valid licence to manufacture or import including all annexures is required; certified copies required; preference is given to locally produced products. - A valid licence to manufacture/import/distribute/wholesale Complementary Medicines (in the name of the bidder) is required; certified copies required. - All annexures and DA02 product list for Complementary Medicines must be provided; certified copies required. - A valid licence to manufacture/import/distribute/wholesale a medical device or in vitro diagnostic (IVD) is required; certified copies required. - Valid Medicine Registration Certificates (MRC) for all products offered are mandatory; each MRC must be marked with the relevant item number and sorted/filed in numerical order; certified copies required. - MRC Annexures as issued by SAHPRA must be provided; certified copy required. - A valid Variation Summary for any changes on the MRC per SAHPRA Guideline: BAU VARIATIONS COMMUNICATION (latest version) must be provided where applicable; certified copies required. - Good Manufacturing Practice (GMP) compliance declaration (PBD 5) is mandatory; must be signed by the authorised signatory per PBD 3. - Special Requirements and Conditions of Contract (SRCC) and General Conditions of Contract (GCC) must be copied and initialled on every page. - Original Package Insert (PI) or QR code with professional information approved by the MCC or SAHPRA must be submitted for each product offered. - Proof of sample submission is required (administrative). - Bidder's item list (list of products offered) must be provided. - Third-party sourced products require: PBD 1 (Third Party Authorisation Declaration), PBD 1.1 (List of products offered sourced from third party), and PBD 1.2 (Unconditional written undertaking from the third party or formal letter).

What financial requirements apply to bidders?

Pricing: - A signed Excel Bid Response (Pricing Schedule) must be submitted; if not signed in the space provided, the bid will not be considered for evaluation. Financial declarations: - PBD 11: Declaration of Financial Solvency and Business Rescue Status is mandatory. - SBD 5: The National Industrial Participation Programme declaration is mandatory for the bidding entity. - SBD 6.1: Preference Points Claim form must be completed to indicate preference points claimed. - Valid B-BBEE Certificate (SANAS accredited) or Sworn Affidavit (EME/QSE) is mandatory where applicable for preference point claims.

What compliance and legal requirements must bidders meet?

Mandatory compliance documents: - CSD Registration report – Mandatory - SARS Tax Clearance Pin – Mandatory - CIPC registration certificate – Mandatory - Valid B-BBEE Certificate (SANAS accredited) – Mandatory where applicable - Sworn Affidavit – Exempted Micro Enterprise (EME) – Mandatory where applicable - Sworn Affidavit – Qualified Small Enterprise (QSE) – Mandatory where applicable - PBD 11: Declaration of Financial Solvency and Business Rescue Status – Mandatory - PBD 5: Good Manufacturing Practice (GMP) Declaration of compliance – Mandatory (authorised signatory per PBD 3 to sign) - SBD 5: National Industrial Participation Programme – Mandatory for bidding entity - SBD 4: Declaration of Interest – Mandatory for bidding entity - SBD 6.1: Preference Points Claim – Mandatory - SBD 1: Invitation to Bid – Mandatory for bidding entity - PBD 3: Bid Signature Authorisation (original or certified copy) – Mandatory - Valid licence to manufacture or import (in the name of the bidder) including all annexures – Mandatory (certified copies required) - Valid licence to manufacture or import for local manufacturing sites as listed on the MRC – Mandatory (certified copies required; preference for locally produced products) - Valid licence to manufacture/import/distribute/wholesale Complementary Medicines – Mandatory (certified copies required) - Valid licence to manufacture/import/distribute/wholesale a medical device or IVD – Mandatory (certified copies required) - Valid Medicine Registration Certificates (MRC) – Mandatory (marked with item numbers, sorted numerically; certified copies required) - PBD 8: SRCC and GCC Declaration of compliance – Mandatory for bidding entity (authorised signatory per PBD 3 to sign) - Copy of Special Requirements and Conditions of Contract (SRCC) – initial every page – Mandatory - Copy of General Conditions of Contract (GCC) – initial every page – Mandatory Administrative documents (required unless not applicable, in which case "N/A" with justification must be indicated): - Covering Letter - Bid/File Index - PBD 4.1: Contact Details of Bidder - CIPC notice of change in Directors - Proof of company ceding, mergers, acquisition, and name changes - PBD 9.1: Entity Directors (if single bidding entity) - PBD 9.2: Multi-entity Bid (if multi bidding entity) - Identification documents of Directors (certified copies required) - Multi-entity Bids: Certified copy of relevant agreement between entities including all other mandatory documents per Section 7.13 - All annexures and DA02 product list for Complementary Medicines (certified copies required) - MRC Annexures as issued by SAHPRA (certified copy required) - Valid Variation Summary for MRC changes per SAHPRA Guideline (certified copies required) - PBD 1: Third Party Authorisation Declaration - PBD 1.1: List of products offered sourced from third party - PBD 1.2: Unconditional written undertaking from third party or formal letter - Original Package Insert (PI) or QR code with professional information approved by MCC/SAHPRA (per product offered) - Proof of sample submission - Bidder's item list (list of products offered)

Supply and Delivery of Drops, Aerosols and Inhaled Medicines

At a GlanceAI Enhanced

Tender Type

Request for Bid(Open-Tender)

Delivery Location

1112 Voortrekker Road - Pretoria Townlands 351-JR - Pretoria - 0001

Organization Type

GOVERNMENT

Published

31 Aug 2026

OCDS Reference

ocds-9t57fa-167565

Summary

The department of health requires suppliers of drops, aerosols and inhaled medicines to submit invoices that strictly follow the annexure b data dictionary. Every invoice must contain all mandated header, supplier, delivery, order, line-item, summary, pay-office and proof-of-delivery fields, with pricing fixed per the contract circular to four decimal places VAT inclusive. Non-compliant invoices will be rejected and payment withheld.

Key Requirements

Invoice header must be TAX INVOICE (original), COPY TAX INVOICE (Supplier Copy) or COPY TAX INVOICE (Customer Copy).

Supplier details on every invoice: logo, name as per contract, NDoH Supplier Code, CSD registration number (MAAA), company registration number, VAT number, authorised distributor name.

Supplier contact details: physical and postal addresses, queries phone and email, debtors phone and email.

'Deliver To' fields per Purchase Order: supplier account number, facility name, demander code, MHFL number, delivery address, receiver name/rank, facility phone.

Invoice details: unique invoice number, 1D barcode of invoice number, invoice date, page numbering.

Order details per Purchase Order: PO number (one per invoice), PO barcode, order captured date, special instructions.

Line items per product: EAN 13 barcode, generic description, brand name, contract/addenda/item reference (format Contract#_Addendum#_Item#), quantity ordered, quantity supplied, batch number (separate line per batch), expiry date (separate line per expiry), unit price VAT inclusive to 4 decimals including delivery, line total.

Summary totals: total excluding VAT (2 decimals), VAT amount (2 decimals), total including VAT (2 decimals).

'Invoice To' details per Purchase Order: pay office name, address, VAT number, phone.

Proof of delivery: date received, receiver printed name and PERSAL number, signature, cartons received, facility stamp space, GRV number space, claim reference if applicable.

Supplier must be CSD-registered (MAAA number) and hold valid company registration and VAT registration.

All Annexure B fields are mandatory; incomplete invoices will be rejected.

Back to All Tenders

Next Tender

Submission Guidelines

Source: 3. HP07-2026DAI_01_Annexure A_Final_28 August 2026.xlsx (unknown)

Submission format and sequence:

All bid documents must be sorted, filed, and submitted in the exact order listed in the returnable documents schedule (Annexure A).
Each compilation sequence (document) must be saved as a separate file on the USB flash drive, using the admin code abbreviations in the file name.
A digital copy of the completed bid must be provided on a USB flash drive (Set 2 & 3).
The Excel Bid Response (Pricing Schedule) must be signed in the space provided; unsigned pricing schedules will result in the bid not being considered for evaluation.
If a specific document is not applicable, the bidder must explicitly indicate "N/A" and provide a justification for its exclusion. Sections blacked out in the "N/A" field are not valid selection options.

Mandatory returnable forms and documents:

Covering Letter (CL) – Administrative
Bid/File Index (BFI) – Administrative
PBD 3: Bid Signature Authorisation (original or certified copy) – Mandatory
SBD 1: Invitation to Bid – Mandatory for bidding entity
PBD 4.1: Contact Details of Bidder – Administrative
CSD Registration report – Mandatory
SARS Tax Clearance Pin – Mandatory
CIPC registration certificate – Mandatory
CIPC notice of change in Directors – Administrative
Proof of company ceding, mergers, acquisition, and name changes – Administrative
PBD 9.1: Entity Directors – Administrative (if single bidding entity)
PBD 9.2: Multi-entity Bid – Administrative (if multi bidding entity)
Identification documents of Directors in PBD 9.1 or PBD 9.2 – Administrative (certified copies required)
SBD 4: Declaration of Interest – Mandatory for bidding entity
SBD 6.1: Preference Points Claim – Mandatory
Valid B-BBEE Certificate (SANAS accredited) – Mandatory where applicable
Sworn Affidavit – Exempted Micro Enterprise (EME) – Mandatory where applicable
Sworn Affidavit – Qualified Small Enterprise (QSE) – Mandatory where applicable
Multi-entity Bids: Certified copy of relevant agreement between entities including all other mandatory documents as specified in Section 7.13 – Mandatory
PBD 11: Declaration of Financial Solvency and Business Rescue Status – Mandatory
PBD 5: Good Manufacturing Practice (GMP) Declaration of compliance – Mandatory (authorised signatory per PBD 3 to sign)
SBD 5: National Industrial Participation Programme – Mandatory for bidding entity
Valid licence to manufacture or import (in the name of the bidder), including all annexures – Mandatory (certified copies required)
Valid licence to manufacture or import for local manufacturing sites as listed on the MRC – Mandatory (preference for locally produced products; certified copies required)
Valid licence to manufacture/import/distribute/wholesale Complementary Medicines – Mandatory (certified copies required)
All annexures and DA02 product list for Complementary Medicines – Administrative (certified copies required)
Valid licence to manufacture/import/distribute/wholesale a medical device or IVD – Mandatory (certified copies required)
Valid Medicine Registration Certificates (MRC) – Mandatory (all MRCs to be marked with relevant item number, sorted and filed in numerical order; certified copies required)
MRC Annexures as issued by SAHPRA – Administrative (certified copy required)
Valid Variation Summary for any changes on the MRC per SAHPRA Guideline: BAU VARIATIONS COMMUNICATION latest version – Administrative (certified copies required)
PBD 1: Third Party Authorisation Declaration – Administrative
PBD 1.1: List of products offered sourced from third party – Administrative
PBD 1.2: Unconditional written undertaking from the third party or formal letter – Administrative
Original Package Insert (PI), QR code with professional information approved by MCC or SAHPRA – Administrative (for each product offered)
Proof of sample submission – Administrative
Bidder's item list (list of products offered) – Administrative
PBD 8: SRCC and GCC Declaration of compliance – Mandatory for bidding entity (authorised signatory per PBD 3 to sign)
Copy of Special Requirements and Conditions of Contract (SRCC) – initial every page – Mandatory
Copy of General Conditions of Contract (GCC) – initial every page – Mandatory
Signed Excel Bid Response (Pricing Schedule) – Mandatory

Technical Specifications

Source: 3. HP07-2026DAI_01_Annexure A_Final_28 August 2026.xlsx (unknown)

Scope: Supply and delivery of pharmaceutical products — drops, aerosols and inhaled medicines — to the Department of Health for the period ending 31 August 2029.

Regulatory and technical requirements:

Bidders must hold a valid licence to manufacture or import (in the name of the bidder) including all annexures; certified copies required.
For local manufacturing sites listed on the Medicine Registration Certificate (MRC), a valid licence to manufacture or import including all annexures is required; certified copies required; preference is given to locally produced products.
A valid licence to manufacture/import/distribute/wholesale Complementary Medicines (in the name of the bidder) is required; certified copies required.
All annexures and DA02 product list for Complementary Medicines must be provided; certified copies required.
A valid licence to manufacture/import/distribute/wholesale a medical device or in vitro diagnostic (IVD) is required; certified copies required.
Valid Medicine Registration Certificates (MRC) for all products offered are mandatory; each MRC must be marked with the relevant item number and sorted/filed in numerical order; certified copies required.
MRC Annexures as issued by SAHPRA must be provided; certified copy required.
A valid Variation Summary for any changes on the MRC per SAHPRA Guideline: BAU VARIATIONS COMMUNICATION (latest version) must be provided where applicable; certified copies required.
Good Manufacturing Practice (GMP) compliance declaration (PBD 5) is mandatory; must be signed by the authorised signatory per PBD 3.
Special Requirements and Conditions of Contract (SRCC) and General Conditions of Contract (GCC) must be copied and initialled on every page.
Original Package Insert (PI) or QR code with professional information approved by the MCC or SAHPRA must be submitted for each product offered.
Proof of sample submission is required (administrative).
Bidder's item list (list of products offered) must be provided.
Third-party sourced products require: PBD 1 (Third Party Authorisation Declaration), PBD 1.1 (List of products offered sourced from third party), and PBD 1.2 (Unconditional written undertaking from the third party or formal letter).

Compliance Requirements

Source: 3. HP07-2026DAI_01_Annexure A_Final_28 August 2026.xlsx (unknown)

Mandatory compliance documents:

CSD Registration report – Mandatory
SARS Tax Clearance Pin – Mandatory
CIPC registration certificate – Mandatory
Valid B-BBEE Certificate (SANAS accredited) – Mandatory where applicable
Sworn Affidavit – Exempted Micro Enterprise (EME) – Mandatory where applicable
Sworn Affidavit – Qualified Small Enterprise (QSE) – Mandatory where applicable
PBD 11: Declaration of Financial Solvency and Business Rescue Status – Mandatory
PBD 5: Good Manufacturing Practice (GMP) Declaration of compliance – Mandatory (authorised signatory per PBD 3 to sign)
SBD 5: National Industrial Participation Programme – Mandatory for bidding entity
SBD 4: Declaration of Interest – Mandatory for bidding entity
SBD 6.1: Preference Points Claim – Mandatory
SBD 1: Invitation to Bid – Mandatory for bidding entity
PBD 3: Bid Signature Authorisation (original or certified copy) – Mandatory
Valid licence to manufacture or import (in the name of the bidder) including all annexures – Mandatory (certified copies required)
Valid licence to manufacture or import for local manufacturing sites as listed on the MRC – Mandatory (certified copies required; preference for locally produced products)
Valid licence to manufacture/import/distribute/wholesale Complementary Medicines – Mandatory (certified copies required)
Valid licence to manufacture/import/distribute/wholesale a medical device or IVD – Mandatory (certified copies required)
Valid Medicine Registration Certificates (MRC) – Mandatory (marked with item numbers, sorted numerically; certified copies required)
PBD 8: SRCC and GCC Declaration of compliance – Mandatory for bidding entity (authorised signatory per PBD 3 to sign)
Copy of Special Requirements and Conditions of Contract (SRCC) – initial every page – Mandatory
Copy of General Conditions of Contract (GCC) – initial every page – Mandatory

Administrative documents (required unless not applicable, in which case "N/A" with justification must be indicated):

Covering Letter
Bid/File Index
PBD 4.1: Contact Details of Bidder
CIPC notice of change in Directors
Proof of company ceding, mergers, acquisition, and name changes
PBD 9.1: Entity Directors (if single bidding entity)
PBD 9.2: Multi-entity Bid (if multi bidding entity)
Identification documents of Directors (certified copies required)
Multi-entity Bids: Certified copy of relevant agreement between entities including all other mandatory documents per Section 7.13
All annexures and DA02 product list for Complementary Medicines (certified copies required)
MRC Annexures as issued by SAHPRA (certified copy required)
Valid Variation Summary for MRC changes per SAHPRA Guideline (certified copies required)
PBD 1: Third Party Authorisation Declaration
PBD 1.1: List of products offered sourced from third party
PBD 1.2: Unconditional written undertaking from third party or formal letter
Original Package Insert (PI) or QR code with professional information approved by MCC/SAHPRA (per product offered)
Proof of sample submission
Bidder's item list (list of products offered)

Document4. HP07-2026DAI_01_Annexure B_ Invoice requirements_28 August 2026.pdfReview complete

Description

Source: 4. HP07-2026DAI_01_Annexure B_ Invoice requirements_28 August 2026.pdf

Contract scope: supply and delivery of pharmaceutical products — drops, aerosols, and inhaled medicines — to the Department of Health for the period ending 31 August 2029.

Products identified by generic description, brand name, and contract/addenda/item number (format Contract#_Addendum#_Item#).
Each sales unit carries an EAN 13 barcode.
Deliveries made against official Purchase Orders; one Purchase Order per invoice.
Batch tracking and expiry date recording required per delivery line.
Pricing per Contract Circular or addendum, VAT inclusive to four decimal places, inclusive of delivery.
Proof of delivery requires facility stamp, GRV number, receiver's PERSAL number and signature, and carton count.

Important Dates

Source: 4. HP07-2026DAI_01_Annexure B_ Invoice requirements_28 August 2026.pdf (unknown)

Contract period ends 31 August 2029. No other dates specified in this document.

Contact Information

Source: 4. HP07-2026DAI_01_Annexure B_ Invoice requirements_28 August 2026.pdf (unknown)

{"name":null,"email":null,"phone":null,"department":"OF HEALTH FOR THE PERIOD","address":"butor name Name of authorised distributor"}

Submission Guidelines

Source: 4. HP07-2026DAI_01_Annexure B_ Invoice requirements_28 August 2026.pdf (unknown)

Invoice submission requirements:

Invoices must include all minimum data fields specified in Annexure B for products delivered under this contract.
Invoice header must be one of: TAX INVOICE (original), COPY TAX INVOICE (Supplier Copy), or COPY TAX INVOICE (Customer Copy).
Supplier information (not distributor) required: logo, name as per contract, NDoH Supplier Code, CSD registration number (MAAA), company registration number, VAT number, and authorised distributor name.
Supplier contact information required: physical and postal addresses, queries contact number and email, debtors contact number and email.
'Deliver To' information required: supplier account number, facility name, demander code, Master Health Facility Number (MHFL), delivery address, name/rank of person delegated to receive delivery, facility contact number — all as per Purchase Order.
Invoice details required: unique invoice number, 1D barcode of invoice number, invoice date, page numbering (e.g., 1 of 3).
Order details required: Purchase Order number (one per invoice), Purchase Order barcode, order captured date, special instruction notes as per Purchase Order.
Invoice line information required per item: EAN 13 barcode, generic product description, brand name, contract/addenda/item number (format Contract#_Addendum#_Item# with two-digit addenda and three-digit item), quantity ordered, quantity supplied, batch number (separate line per batch), expiry date (separate line per expiry), unit price VAT inclusive to 4 decimal places, line total.
Summary invoice totals required: total excluding VAT (2 decimal places), VAT amount (2 decimal places), total including VAT (2 decimal places).
'Invoice To' information required: pay office name and address, pay office VAT number, pay office phone — all as per Purchase Order.
'Goods Received By' (Proof of Delivery) required: date received, printed name and PERSAL number of receiver, signature, number of cartons received, facility stamp space, GRV number space, claim reference number if relevant.
All fields must be present on every invoice; incomplete invoices may be rejected.

Technical Specifications

Source: 4. HP07-2026DAI_01_Annexure B_ Invoice requirements_28 August 2026.pdf (unknown)

Supply and delivery of pharmaceutical products: drops, aerosols, and inhaled medicines to the Department of Health.

Products must match generic product description and brand name as per Contract Circular and Purchase Order.
Each invoice line must reference contract number, addenda number (two placeholders), and item number (three placeholders) corresponding to the generic product description.
Batch numbers and expiry dates must be recorded per line; multiple batches or expiries for the same product require separate lines with respective quantities.
Unit price must be as per Contract Circular or addendum, VAT inclusive, to four decimal places, and must include delivery.
Items identified by EAN 13 barcode as appearing on a single sales unit.
Deliveries must reference a single Purchase Order per invoice.
Proof of delivery requires facility stamp, GRV number, and receiver's PERSAL number and signature.

Financial Requirements

Source: 4. HP07-2026DAI_01_Annexure B_ Invoice requirements_28 August 2026.pdf (unknown)

Pricing and invoicing terms:

Unit prices are fixed per Contract Circular or addendum, VAT inclusive, to four decimal places, and include delivery.
Invoice totals calculated to two decimal places (ex VAT, VAT amount, total incl VAT).
One Purchase Order number per invoice.
No bond, guarantee, or insurance requirements stated in this document.
Payment terms not specified in this document.

Compliance Requirements

Source: 4. HP07-2026DAI_01_Annexure B_ Invoice requirements_28 August 2026.pdf (unknown)

Mandatory compliance items for invoicing:

Supplier must be registered on the Central Supplier Database (CSD) — CSD registration number (MAAA) required on invoices.
Valid company registration number and VAT number required on invoices.
NDoH Supplier Code as per contract circular required on invoices.
Supplier name on invoices must match contract.
Authorised distributor name must be stated on invoices.
All invoice data fields per Annexure B are mandatory for payment processing.

Special Conditions

Source: 4. HP07-2026DAI_01_Annexure B_ Invoice requirements_28 August 2026.pdf (unknown)

Invoice compliance conditions:

All invoices must contain every data field defined in Annexure B; incomplete invoices will not be processed.
Supplier information on invoices must reflect the contracted supplier, not the distributor (though distributor name must be stated).
Invoice header must correctly indicate original or copy status.
Unit prices must match Contract Circular or addendum exactly, to four decimal places, VAT inclusive.
Batch and expiry details must be split across separate lines where multiple exist for a product.
Proof of delivery section must provide space for facility stamp without obscuring invoice details.
GRV number and claim reference number fields must be available on the invoice.
Only one Purchase Order number permitted per invoice.
Special instructions from the Purchase Order (e.g., emergency orders) must be carried onto the invoice.

Document1. HP07-2026DAI_01__Invitation to bid_ notice_for NDOH website_28 August 2026.pdfReview complete

Important Dates

Source: 1. HP07-2026DAI_01__Invitation to bid_ notice_for NDOH website_28 August 2026.pdf (TENDER)

Closing date and time: 28 September 2026 at 11:00 am (submission to physical tender box).

Non-compulsory online briefing session: 18 September 2026 at 10:00 via MS Teams (link: https://teams.microsoft.com/meet/314436122800593?p=CVfQjt78m3LX5KlBTX). Attendance is not mandatory but recommended.

Bid document available from 28 August 2026 on the Department of Health website (www.health.gov.za, TENDERS > PHARMACEUTICAL TENDERS) and the National Treasury e-tender portal.

Contact Information

Source: 1. HP07-2026DAI_01__Invitation to bid_ notice_for NDOH website_28 August 2026.pdf (TENDER)

All enquiries: email [email protected] (also referenced as [email protected] for registration-related queries).

Office hours for enquiries: 07:30 – 15:30.

Submission address: DR AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, PRETORIA, 0143.

Submission Guidelines

Source: 1. HP07-2026DAI_01__Invitation to bid_ notice_for NDOH website_28 August 2026.pdf (TENDER)

Submission method: physical delivery to the tender box at DR AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, PRETORIA, 0143. Closing date and time: 28 September 2026 at 11:00 am. Late bids will not be accepted.

Returnable forms — all must be completed, signed and submitted with the bid:

SBD 1 (Invitation to Bid): serves as the offer cover page with bidder and contact details.
SBD 4 (Declaration of Interest): discloses whether any director or shareholder is employed by the state or connected to anyone at the department. A false declaration disqualifies the bid.
SBD 6.1 (Preference Points Claim): claims B-BBEE points under the PPPFA 80/20 or 90/10 system.
SBD 6.2 (Declaration for Local Production and Content): declares local content compliance where designated sectors apply.
SBD 8 (Declaration of Past Supply Chain Management Practices): declares any past restrictions or terminations.
SBD 9 (Certificate of Independent Bid Determination): certifies the price was set independently, with no contact with competing bidders.
Authority to Sign / Board Resolution: authorises the named signatory to bind the bidder.

Mandatory administrative requirements (Phase I): CSD registration, valid SARS tax compliance status PIN, and all returnable forms completed and signed. Failure to meet any mandatory requirement leads to disqualification.

Evaluation Criteria

Source: 1. HP07-2026DAI_01__Invitation to bid_ notice_for NDOH website_28 August 2026.pdf (TENDER)

Four-phase evaluation:

Phase I — Compliance with mandatory administrative bid requirements (CSD registration, valid tax compliance status PIN, all returnable forms completed and signed). Non-compliant bids are eliminated.

Phase II — Compliance with product, technical and legal mandatory requirements as specified in the bid document (detailed specifications, registration with SAHPRA where applicable, labelling and packaging requirements, delivery terms).

Phase III — B-BBEE compliance evaluated as per Section 9 of the Special Requirements and Conditions of Contract (SRCC). Preference points claimed via SBD 6.1.

Phase IV — Recommendation and award based on the outcome of the preceding phases.

The bid will be evaluated under the PPPFA preference point system (80/20 or 90/10 as indicated in the bid document). Minimum qualifying thresholds for functionality or technical compliance, if any, are detailed in the full bid document.

Technical Specifications

Source: 1. HP07-2026DAI_01__Invitation to bid_ notice_for NDOH website_28 August 2026.pdf (TENDER)

Scope: Supply and delivery of pharmaceutical products — drops, aerosols and inhaled medicines — to the Department of Health for the period ending 31 August 2029.

Detailed product specifications, quantities, packaging, labelling, shelf-life requirements, delivery schedules, and SAHPRA registration requirements are contained in the full bid document (not provided in the invitation notice). Phase II evaluation will assess compliance with these product, technical and legal mandatory requirements.

Compliance Requirements

Source: 1. HP07-2026DAI_01__Invitation to bid_ notice_for NDOH website_28 August 2026.pdf (TENDER)

Mandatory pre-qualification:

Registration on the Central Supplier Database (CSD).
Valid SARS tax compliance status PIN (or tax clearance certificate).
B-BBEE compliance evaluated per Section 9 of the Special Requirements and Conditions of Contract (SRCC); preference points claimed via SBD 6.1.
Completion and signature of all returnable forms: SBD 1, SBD 4, SBD 6.1, SBD 6.2, SBD 8, SBD 9, and Authority to Sign / Board Resolution.
Local production and content requirements may apply for designated sectors (declared via SBD 6.2).
Any additional statutory or regulatory registrations required for pharmaceutical products (e.g., SAHPRA licensing) as specified in the full bid document.

Section

Source: 1. HP07-2026DAI_01__Invitation to bid_ notice_for NDOH website_28 August 2026.pdf

Four-phase evaluation: Phase I — mandatory administrative compliance (CSD, tax, returnable forms); Phase II — product, technical and legal mandatory requirements; Phase III — B-BBEE compliance per Section 9 of the SRCC; Phase IV — recommendation and award. Preference point system (80/20 or 90/10) applies.

Document9. HP07-2026DAI_01_Final BidResp_28 August 2026.xlsxReview complete

Description

Source: 9. HP07-2026DAI_01_Final BidResp_28 August 2026.xlsx

Supply and delivery of 19 pharmaceutical products (drops, aerosols, inhaled medicines) to the Department of Health for the period ending 31 August 2029. Items include ear drops, ophthalmic solutions and strips, inhalers, nasal sprays, respirator solutions, irrigation solutions, and spacer devices. Quantities are estimated for the full tender period. Therapeutic Class 5 applies to Oxymetazoline 0.025% ophthalmic drops and Tetracaine 1% ophthalmic drops.

Important Dates

Source: 9. HP07-2026DAI_01_Final BidResp_28 August 2026.xlsx (unknown)

Closing date: 28 September 2026 at 11:00 (from tender record). No compulsory briefing session, site visit, or clarification deadline is mentioned in the extracted content.

Contact Information

Source: 9. HP07-2026DAI_01_Final BidResp_28 August 2026.xlsx (unknown)

No SCM or technical contact details, email addresses, phone numbers, or submission address are provided in the extracted workbook.

Submission Guidelines

Source: 9. HP07-2026DAI_01_Final BidResp_28 August 2026.xlsx (unknown)

Submission format: The bid response is an Excel workbook (HP07-2026DAI_01_Final BidResp_28 August 2026.xlsx) with a sheet named "HP07-2026DAI_01_Bid Response". Bidders must complete all required fields for each item offered, including delivered price per unit (two decimals, not exceeding the current Single Exit Price), delivered price per shipper pack, product registration details, licence to manufacture medicines (number and expiry date), pack sizes, lead times (initial ≤75 calendar days, ongoing ≤14 calendar days), minimum order quantity, batch size, monthly batch capacity, barcode details (EAN-13 for unit and shelf packs, ITF-14 for shipper pack, 2D barcode), NAPPI code, distributor and manufacturer details (primary, secondary, tertiary), API source details (up to three sources with site name, address, country, contact), and cost breakdown percentages (API, formulation, packaging, logistics, gross margin) with local/imported splits. Currency must be selected from the listed options (ZAR, USD, GBP, EUR, DKK, CHF, AUD, INR, CNY, Other). A declaration on whether a technical amendment is required must be made. Standard National Treasury returnable forms (SBD 1, SBD 4, SBD 6.1, SBD 8, SBD 9, Authority to Sign/Board Resolution) are expected but not detailed in the extracted workbook.

Evaluation Criteria

Source: 9. HP07-2026DAI_01_Final BidResp_28 August 2026.xlsx (unknown)

Evaluation criteria are not explicitly detailed in the extracted workbook. Mandatory compliance requirements include: registration on the Central Supplier Database (CSD), valid SAHPRA product registration for each item offered, valid licence to manufacture medicines (number and expiry date), and adherence to Single Exit Price (SEP) regulations (bid price may not exceed current SEP per unit). No minimum B-BBEE level, CIDB grade, local content threshold, or functionality/price scoring split is stated in the provided content.

Technical Specifications

Source: 9. HP07-2026DAI_01_Final BidResp_28 August 2026.xlsx (unknown)

Scope: Supply and delivery of 19 pharmaceutical products (drops, aerosols, inhaled medicines) to the Department of Health for the period ending 31 August 2029. Items and specifications:

Acetic Acid 2% in Alcohol 50%, ear drops; 10 ml (Unit: Each; Estimate: 420,410)
Acetylcholine 20 mg/2 ml, ophthalmic solution; 2 ml (Each; 7,540)
Fluorescein 1 mg, ophthalmic sterile strips; Box of 100 (Box of 100 strips; 500)
Fluticasone and Salmeterol inhaler, 125 mcg and 25 mcg per actuation; 120 doses (Each; 31,350)
Fluticasone and Salmeterol inhaler, 250 mcg and 25 mcg per actuation; 60 doses (Each; 107,030)
Hyaluronidase 1500 IU, powder for solution; ampoule (Each; 40,300)
Inhaler device (Universal spacer) with mouthpiece, for adults, anti-static material, spacer volume 500 ml, multi-inhaler adaptor (Each; 12,504)
Inhaler device (Universal spacer) with mouthpiece, for children, non-return valve, spacer volume 250–500 ml, anti-static material, multi-inhaler adaptor (Each; 35,230)
Oxybuprocaine 0.4%, ophthalmic drops; 3 ml (Each; 28,770)
Oxymetazoline 0.025%, ophthalmic drops; 15 ml (Each; 3,002,430)
Oxymetazoline 0.05%, nasal spray; 15 ml (Each; 1,868,940)
Pilocarpine 1%, ophthalmic drops; 15 ml (Each; 15,760)
Salbutamol 0.5%, respirator solution; 20 ml (Each; 191,740)
Sodium Chloride 0.9%, isotonic sterile solution for irrigation; 30 ml (Each; 51,170)
Tetracaine 1%, ophthalmic drops; 10 ml (Each; 28,770)
Timolol 0.25%, ophthalmic drops; 5 ml (Each; 31,500)
Tropicamide 1%, ophthalmic drops, single-use applicators, 0.5 ml; Box of 20 (Box of 20; 1,015)
Budesonide/Formoterol inhaler, 80/4.5 mcg per actuation, metered dose; 120 doses (Each; 181,190)

Therapeutic Class 5 applies to items 10 and 15. Quantities shown are estimates for the full tender period.

Financial Requirements

Source: 9. HP07-2026DAI_01_Final BidResp_28 August 2026.xlsx (unknown)

Pricing: Delivered price per unit (two decimals) must not exceed the current Single Exit Price (SEP) for the corresponding unit. Delivered price per shipper pack (two decimals) also required. Currency options: ZAR, USD, GBP, EUR, DKK, CHF, AUD, INR, CNY, Other. Cost breakdown percentages required for each item: % of delivered price attributable to API (with local/imported split), formulation (local/imported split), packaging (local/imported split), logistics, and gross margin. No bid bond, performance guarantee, advance payment terms, or financial capacity thresholds are stated in the extracted content.

Compliance Requirements

Source: 9. HP07-2026DAI_01_Final BidResp_28 August 2026.xlsx (unknown)

Mandatory:

Central Supplier Database (CSD) registration.
Valid SAHPRA product registration number for each item offered.
Valid licence to manufacture medicines (licence number and expiry date).
Compliance with Single Exit Price (SEP) regulations — bid price may not exceed current SEP.
Conformance to item specifications (Y/N declaration with deviation details if non-conforming).

Standard returnable forms expected (not detailed in workbook): SBD 1 (Invitation to Bid), SBD 4 (Declaration of Interest), SBD 6.1 (Preference Points Claim), SBD 8 (Past SCM Practices), SBD 9 (Certificate of Independent Bid Determination), Authority to Sign/Board Resolution.

No explicit B-BBEE level, CIDB grade, CIPC registration, professional body registration, or local content threshold stated.

Document2. HP07-2026DAI_01_BidPackTemplate-28 August 2026.pdfReview complete

Description

Source: 2. HP07-2026DAI_01_BidPackTemplate-28 August 2026.pdf

Supply and delivery of pharmaceutical products — drops, aerosols and inhaled medicines — to the National Department of Health for the period ending 31 August 2029. The tender is governed by the Preferential Procurement Policy Framework Act, Preferential Procurement Regulations 2022, General Conditions of Contract (GCC) and Special Requirements and Conditions of Contract (SRCC). National Industrial Participation (NIP) obligations apply where imported content meets or exceeds US$10 million (or R10 million for reporting). NIP obligation is 30% of imported content, dischargeable within seven years through investments, joint ventures, sub-contracting, licensee production, export promotion, sourcing arrangements or R&D. Successful bidders with contracts exceeding R10 million must report contract details to the DTI within 5 working days of award and engage in the NIP process (performance guarantee, business concept, business plans, bi-annual progress reports).

Important Dates

Source: 2. HP07-2026DAI_01_BidPackTemplate-28 August 2026.pdf (TENDER)

Closing date: 28 September 2026

Closing time: 11:00

Non-compulsory online briefing session: 18 September 2026 at 10:00 via MS Teams

Bid validity period: 180 days from closing date

Contact Information

Source: 2. HP07-2026DAI_01_BidPackTemplate-28 August 2026.pdf (TENDER)

SCM / bidding procedure enquiries: [email protected]

Technical enquiries: [email protected]

Physical submission address: Pharmaceutical Tender Box, Reception Area, National Department of Health, Dr AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, Pretoria 0187

Postal address for DTI NIP reporting (after award): Department of Trade and Industry, Private Bag X84, Pretoria 0001, attention Mr Elias Malapane

NIP programme contacts: Ms R Muthan, telephone (012) 394 1288, mobile (066) 301 2051, email [email protected]

Submission Guidelines

Source: 2. HP07-2026DAI_01_BidPackTemplate-28 August 2026.pdf (TENDER)

Submission method: Physical delivery to the Pharmaceutical Tender Box at the National Department of Health, Dr AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, Pretoria 0187. Bids must be deposited before the closing date and time; late bids will not be accepted. The tender box is accessible during working hours.

Required returnable documents (all must be completed, signed and submitted with the bid):

SBD 1 (Invitation to Bid): signed offer cover page with bidder details.
SBD 4 (Bidder's Disclosure): declares any director/shareholder employed by the state or connected to the procuring institution; false declaration disqualifies the bid.
SBD 6.1 (Preference Points Claim): claims B-BBEE points under the 90/10 system; must be supported by a valid SANAS-accredited B-BBEE certificate or sworn affidavit (EME/QSE).
PBD 3 (Bid Signature Authorisation) for single entities or PBD 3.1 for multi-entity enterprises: confirms authorised signatory; proof of authority (e.g. board resolution) must be attached.
PBD 4.1 (Supplier Details): supplier registration information.
PBD 5 (SBD 5) (National Industrial Participation): declaration and reporting obligations for contracts with imported content exceeding US$10 million or R10 million.
PBD 8 (Declaration of Compliance with SRCC & GCC): confirms compliance with Special Requirements and Conditions of Contract and General Conditions of Contract.
PBD 9.1 (Directors Profile – Single Entity) or PBD 9.2 (Directors Profile – Multi-Entity): director categorisation and ownership details.
PBD 11 (Declaration of Financial Solvency and Business Rescue Status): declares solvency, no business rescue/liquidation proceedings, and undertakes to notify the department of any material financial event within 5 working days.
PBD 1 (Authorisation Declaration): required if sourcing products from a third party; includes third-party undertaking (PBD 1.2).
Proof of CSD registration (MAAA number) and valid tax compliance status (SARS TCS PIN or CSD number).
Foreign suppliers must complete the questionnaire on SBD 1 Part A.

Disqualification risks: any returnable form left unsigned or omitted; bids received after closing time; false declarations on SBD 4, PBD 11 or PBD 1; failure to provide CSD registration or tax compliance proof.

Evaluation Criteria

Source: 2. HP07-2026DAI_01_BidPackTemplate-28 August 2026.pdf (TENDER)

Preference point system: 90/10 (Price 90 points, Specific Goals 10 points).

Price scoring: 90 points allocated using the 90/10 formula (Ps = 90 × (1 - (Pt - Pmin)/Pmin)).

Specific Goals: B-BBEE Status Level of Contributor points per Table 1:

Level 1: 10 points
Level 2: 9 points
Level 3: 8 points
Level 4: 6 points
Level 5: 5 points
Level 6: 4 points
Level 7: 3 points
Level 8: 2 points
Non-compliant contributor: 0 points

Evidence required: valid SANAS-accredited B-BBEE certificate or sworn affidavit (EME/QSE). Failure to submit valid evidence does not render the bid non-responsive but results in zero preference points.

No minimum functionality or qualifying score is stated in the extracted text. Evaluation is subject to the Preferential Procurement Policy Framework Act, Preferential Procurement Regulations 2022, General Conditions of Contract (GCC) and Special Requirements and Conditions of Contract (SRCC).

Technical Specifications

Source: 2. HP07-2026DAI_01_BidPackTemplate-28 August 2026.pdf (TENDER)

Supply and delivery of pharmaceutical products: drops, aerosols and inhaled medicines to the National Department of Health for the period ending 31 August 2029.

Bidders must declare compliance with Good Manufacturing Practice (GMP) via PBD 5: no outstanding or impending GMP or legal matters materially affecting ability to perform; compliance with the Medicines and Related Substances Act for products offered; undertaking to inform the Department at first knowledge of any circumstances that may interrupt supply.

If products are sourced from a third party, the bidder must submit PBD 1 (Authorisation Declaration) with details of the third party and an unconditional written undertaking from the third party (PBD 1.2) to supply the products for the contract duration.

National Industrial Participation (NIP) obligations apply where imported content equals or exceeds US$10 million (or R10 million for reporting). NIP obligation is 30% of imported content, to be discharged within seven years through investments, joint ventures, sub-contracting, licensee production, export promotion, sourcing arrangements or R&D. Successful bidders with contracts exceeding R10 million must report contract details to the DTI within 5 working days of award and submit a performance guarantee to the DTI.

Financial Requirements

Source: 2. HP07-2026DAI_01_BidPackTemplate-28 August 2026.pdf (TENDER)

Pricing: bids must be submitted on the official pricing forms (SBD 3.1/3.2/3.3 as applicable) — not re-typed. No specific pricing format (firm/non-firm/professional services) is detailed in the extracted text.

Performance guarantee: required by the DTI as part of the NIP obligation agreement (not the purchasing institution) for contracts triggering NIP.

Financial solvency: bidders must declare via PBD 11 that they are financially solvent, possess sufficient financial resources, and are not under business rescue, liquidation, sequestration, administration or judicial management, with no pending insolvency applications.

Contract reporting: successful bidders with contracts exceeding R10 million must report contract value and imported content to the DTI within 5 working days of award.

Payment terms: not specified in the extracted text.

Compliance Requirements

Source: 2. HP07-2026DAI_01_BidPackTemplate-28 August 2026.pdf (TENDER)

Mandatory registrations and status:

Central Supplier Database (CSD) registration (MAAA number) — required for all bidders; each party in a consortium/JV/partnership must provide a separate CSD number.
Tax compliance: valid SARS Tax Compliance Status (TCS) PIN or printed TCS certificate; if no TCS PIN, CSD number must be provided. Each party in a consortium/JV/sub-contractor must submit separate TCS PIN/certificate/CSD number.
VAT registration number (if applicable).
CIPC registration (implied by company registration number on forms).

B-BBEE: Preference points claimed via SBD 6.1 supported by valid SANAS-accredited B-BBEE certificate or sworn affidavit (EME/QSE). No minimum B-BBEE level is stipulated for eligibility; points allocated per status level (Level 1 = 10 points down to Non-compliant = 0).

Declarations (all must be signed and submitted):

SBD 4 (Bidder's Disclosure): interest in state employment, relationships with procuring institution, other related enterprises.
PBD 5 (GMP Compliance): compliance with Medicines Act, no material GMP/legal issues.
PBD 8 (Compliance with SRCC & GCC).
PBD 11 (Financial Solvency & Business Rescue Status).
PBD 1 (Authorisation Declaration) if sourcing from third parties.
PBD 3 or PBD 3.1 (Bid Signature Authorisation) with proof of authority.
PBD 4.1 (Supplier Details).
PBD 9.1 or PBD 9.2 (Directors Profile).
SBD 5 (National Industrial Participation) — signed and submitted with bid.

Foreign suppliers: must complete the questionnaire on SBD 1 Part A; if not resident, no branch, no permanent establishment, no RSA-source income and not liable for RSA tax, TCS PIN/CSD registration is not required.

Prohibited: bids from persons in the service of the state, companies with directors in the service of the state, or close corporations with members in the service of the state.

Contractual Terms

Source: 2. HP07-2026DAI_01_BidPackTemplate-28 August 2026.pdf

Contract subject to GCC and SRCC. Successful bidder must sign SBD 7 (Contract Form). NIP obligation agreement (if triggered) is between the successful bidder and the DTI, not the purchasing institution. NIP process: determine obligation, sign agreement, submit performance guarantee to DTI, submit business concept for DTI approval, submit detailed business plans, implement plans, submit bi-annual progress reports. Financial solvency declaration (PBD 11) requires notification to the Department within 5 working days of any material financial event during bid validity or contract term. False declarations may lead to disqualification, contract termination, reporting to National Treasury for restriction, and/or legal action. GMP compliance declaration (PBD 5) requires immediate notification of any circumstances that may interrupt supply. Third-party sourcing requires unconditional written undertaking from the third party (PBD 1.2) for the contract duration.

Section

Source: 2. HP07-2026DAI_01_BidPackTemplate-28 August 2026.pdf

Preference point system: 90/10 (Price 90 points, Specific Goals 10 points). Price scored using the 90/10 formula. Specific Goals points awarded for B-BBEE Status Level of Contributor: Level 1 = 10, Level 2 = 9, Level 3 = 8, Level 4 = 6, Level 5 = 5, Level 6 = 4, Level 7 = 3, Level 8 = 2, Non-compliant = 0. Evidence: valid SANAS-accredited B-BBEE certificate or sworn affidavit (EME/QSE). Failure to submit evidence results in zero preference points but does not render the bid non-responsive. No minimum functionality threshold or qualifying score stated.

Document5. HP04-2026ONC_01-Annexure_C_Guidance_QSE_EME_31 July 2026.pdfReview complete

Contact Information

Source: 5. HP04-2026ONC_01-Annexure_C_Guidance_QSE_EME_31 July 2026.pdf (unknown)

{"name":null,"email":null,"phone":null,"department":null,"address":"or member."}

Evaluation Criteria

Source: 5. HP04-2026ONC_01-Annexure_C_Guidance_QSE_EME_31 July 2026.pdf (unknown)

Preference points for specific goals are claimed through a valid B-BBEE QSE/EME sworn affidavit. An incorrectly completed affidavit is deemed invalid and no preference points will be allocated. Bidders with annual turnover exceeding R50 million must submit a valid SANAS-accredited B-BBEE certificate and do not qualify to use the EME/QSE sworn affidavit.

Compliance Requirements

Source: 5. HP04-2026ONC_01-Annexure_C_Guidance_QSE_EME_31 July 2026.pdf (unknown)

B-BBEE compliance: QSEs have annual turnover between R10 million and R50 million; EMEs have annual turnover of R10 million or less. Bidders exceeding R50 million turnover must submit a valid SANAS-accredited B-BBEE certificate. A valid QSE/EME sworn affidavit must include: deponent name and ID number as per identity document; deponent designation (director, owner or member); enterprise name and address as per CIPC registration; percentages of black ownership, black female ownership and designated group ownership; total revenue for the year under review and whether based on audited financial statements or management accounts; financial year end per registration documents; single B-BBEE status level; empowering supplier status (QSEs must select the basis); matching deponent and Commissioner of Oaths signature dates; Commissioner of Oaths must not be an employee or ex officio of the enterprise.

B-BBEE Requirements

Source: 5. HP04-2026ONC_01-Annexure_C_Guidance_QSE_EME_31 July 2026.pdf (unknown)

Section

Source: 5. HP04-2026ONC_01-Annexure_C_Guidance_QSE_EME_31 July 2026.pdf

Supply and delivery of drops, aerosols and inhaled medicines — invoice compliance requirements

Related active categories

Active provinces

Active buying organisations

Intelligence and resources

Tender context

Related active categories

Active provinces

Active buying organisations

Intelligence and resources

Eligibility Criteria

Healthcare & Medical Services Industry Profile

Critical Requirements

Regulatory Bodies

Typical Documents

Core procurement rules

Broad-Based Black Economic Empowerment Act (B-BBEE Act)

Constitution of the Republic of South Africa, 1996 – Section 217

Health

Similar Tenders

PROVISION OF PSYCHOMETRIC ASSESSMENT SERVICES FOR A PERIOD OF THREE YEARS

Supplier Readiness Hub

Preferential Procurement Policy Framework Act (PPPFA)

Prevention and Combating of Corrupt Activities Act (PRECCA)

Public Procurement Act, 2024 (PPA)

Promotion of Access to Information Act (PAIA)

Promotion of Administrative Justice Act (PAJA)

Sector-specific rules

National Health Act

Occupational Health and Safety Act (OHS Act)

Medical Equipment Maintenance: Winning Hospital Service Contracts

Provincial Hospital Tenders for Medical Equipment and Maintenance: Winning Contracts with SA Health Departments

Healthcare JVs for SMMEs: Small Medical Firms Winning Government Health Tenders

Enterprise Healthcare JVs: Large Medical Suppliers and SAHPRA Compliance

PROVISION OF PSYCHOMETRIC ASSESSMENT SERVICES FOR A PERIOD OF THREE YEARS

Bidders list for the provision of LV Maintenance and Refurbishment for Eskom Distribution Network, on an “as-and-when” required basis for a period of three (3) years in Gauteng Cluster

Supply and Delivery of Boiler Internal Tubing for Grootvlei Power Station Units 1 to 3 on an As-and-When-Required Basis

ADVERTISEMENT: APPOINTMENT OF A SERVICE PROVIDER FOR THE SUPPLY, DELIVERY AND OFFLOADING OF INSECTICIDES AND RODENTICIDES TO THE POISON STORE (S010)

The Road Accident Fund (RAF) wishes to appoint a suitably qualified Verification Agency to conduct annual assessments for the RAF and issue reports and B-BBEE certificates for a period of three (3) years

Supply, installation and delivery of Smart TV

Supply and delivery of drops, aerosols and inhaled medicines — invoice compliance requirements

Related opportunities

Related active categories

Active provinces

Active buying organisations

Intelligence and resources

Tender context

Related opportunities

Related active categories

Active provinces

Active buying organisations

Intelligence and resources

Eligibility Criteria

Healthcare & Medical Services Industry Profile

Critical Requirements

Regulatory Bodies

Typical Documents

Core procurement rules

Broad-Based Black Economic Empowerment Act (B-BBEE Act)

Constitution of the Republic of South Africa, 1996 – Section 217

Health

Similar Tenders

PROVISION OF PSYCHOMETRIC ASSESSMENT SERVICES FOR A PERIOD OF THREE YEARS

Supplier Readiness Hub

Preferential Procurement Policy Framework Act (PPPFA)

Prevention and Combating of Corrupt Activities Act (PRECCA)

Public Procurement Act, 2024 (PPA)

Promotion of Access to Information Act (PAIA)

Promotion of Administrative Justice Act (PAJA)

Sector-specific rules

National Health Act

Occupational Health and Safety Act (OHS Act)

Medical Equipment Maintenance: Winning Hospital Service Contracts

Provincial Hospital Tenders for Medical Equipment and Maintenance: Winning Contracts with SA Health Departments

Healthcare JVs for SMMEs: Small Medical Firms Winning Government Health Tenders

Enterprise Healthcare JVs: Large Medical Suppliers and SAHPRA Compliance

PROVISION OF PSYCHOMETRIC ASSESSMENT SERVICES FOR A PERIOD OF THREE YEARS

Bidders list for the provision of LV Maintenance and Refurbishment for Eskom Distribution Network, on an “as-and-when” required basis for a period of three (3) years in Gauteng Cluster

Supply and Delivery of Boiler Internal Tubing for Grootvlei Power Station Units 1 to 3 on an As-and-When-Required Basis

ADVERTISEMENT: APPOINTMENT OF A SERVICE PROVIDER FOR THE SUPPLY, DELIVERY AND OFFLOADING OF INSECTICIDES AND RODENTICIDES TO THE POISON STORE (S010)

The Road Accident Fund (RAF) wishes to appoint a suitably qualified Verification Agency to conduct annual assessments for the RAF and issue reports and B-BBEE certificates for a period of three (3) years

Supply, installation and delivery of Smart TV